Biohaven Stock Crashes After Protein-Degrading Drug Misses Expectations
Biohaven stock crashed Wednesday after the company's experimental protein-degrading drug lagged investor expectations.
Source: investors.com
Stay updated with breaking news from Rivaling Argenx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biohaven stock crashed Wednesday after the company's experimental protein-degrading drug lagged investor expectations.